4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-22-060689
Chief Executive Officer bought 15,985 shares at an average $1.88 ($30,020)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2022-12-08 | Purchase | +3,050 | $1.70 | $5,185 | 28,050 | D |
| Tak Paul Peter Chief Executive Officer | 2022-12-09 | Purchase | +12,935 | $1.92 | $24,835 | 40,985 | D |
| Open-market purchases · 15,985 sh · avg $1.88 · $30,020 | |||||||
Loading xslF345X03/doc4.xml…